☆ 4.3 Editorial Material

Pembrolizumab monotherapy in advanced NSCLC patients with low PD-L1 expression: is there real evidence?

TRANSLATIONAL CANCER RESEARCH (2019)

Get Full Text
Add to Collection

Journal

TRANSLATIONAL CANCER RESEARCH
Volume 8, Issue -, Pages S618-S620

Publisher

AME PUBL CO
DOI: 10.21037/tcr.2019.06.28

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.